EARLY INITIATION OF ADALIMUMAB SIGNIFICANTLY DIMINISHES ENDOSCOPIC POST-OPERATIVE CROHN'S DISEASE RECURRENCE, AND IS SUPERIOR TO IMMUNOMODULATORY THERAPY, REGARDLESS OF RISK STRATIFICATION. A RANDOMIZED, CONTROLLED STUDY

Erez Scapa  1     Naomi Fliss-Isakov  2     Hagit Tulchinsky  3     Henit Yanai  4     Ian White  5     Iris Dotan  6     Nitsan Maharshak    
1 Tel Aviv Sourasky Medical Centre Dept. of Gastroenterology,Ramat Hasharon,Israel
2 Tel Aviv Sourasky Medical Center,Tel Aviv,Israel
3 Tel Aviv Sourasky Medical Center, Israel,Tel Aviv,Israel
4 Rabin Medical Center IBD center Gastroenterology and Liver Diseases,Tel Aviv,Israel
5 Meir Medical Center,Kfar Saba,Israel
6 Rabin Medical Center -

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing